o-Cresyl phosphate


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D001259 Ataxia PMID:19428928; PMID:22974967
MESH:D004487 Edema PMID:26757727
MESH:D007794 Lameness, Animal PMID:24338829
MESH:D009128 Muscle Spasticity PMID:666613
MESH:D009410 Nerve Degeneration PMID:3961813
MESH:D009422 Nervous System Diseases PMID:3961813
MESH:D009443 Neuritis PMID:13019039; PMID:861083
MESH:D009461 Neurologic Manifestations PMID:3205432
MESH:D009845 Oligospermia PMID:22450445
MESH:D010243 Paralysis PMID:13019039; PMID:20221861; PMID:24338829; PMID:6665797; PMID:793467
MESH:D011115 Polyneuropathies PMID:666613; PMID:7713347; PMID:793467
MESH:D020258 Neurotoxicity Syndromes PMID:19914363; PMID:22366639; PMID:23743148; PMID:6520887
MESH:D020964 Embryo Loss PMID:31566301
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:26757727
MESH:D058186 Acute Kidney Injury PMID:29154782

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.